Wetherby Asset Management Inc Horizon Therapeutics Public LTD CO Transaction History

Wetherby Asset Management Inc

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$98.98 - $115.74 $24,646 - $28,819	-249 Reduced 7.14%	3,238 $374,000
Q2 2023 Aug 14, 2023	SELL	$96.34 - $112.38 $3,082 - $3,596	-32 Reduced 0.91%	3,487 $358,000
Q1 2023 May 12, 2023	SELL	$107.32 - $113.5 $6,224 - $6,583	-58 Reduced 1.62%	3,519 $384,000
Q4 2022 Feb 14, 2023	BUY	$62.39 - $113.8 $2,807 - $5,121	45 Added 1.27%	3,577 $407,000
Q3 2022 Nov 14, 2022	BUY	$58.92 - $84.67 $208,105 - $299,054	3,532 New	3,532 $219,000

Q2 2022 Aug 15, 2022	SELL	$79.4 - $116.36 $184,843 - $270,886	-2,328 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$86.42 - $109.81 $10,975 - $13,945	-127 Reduced 5.17%	2,328 $245,000
Q4 2021 Feb 14, 2022	BUY	$98.56 - $119.91 $4,435 - $5,395	45 Added 1.87%	2,455 $265,000
Q3 2021 Nov 15, 2021	BUY	$91.91 - $110.37 $14,797 - $17,769	161 Added 7.16%	2,410 $264,000
Q2 2021 Aug 16, 2021	BUY	$86.24 - $95.92 $193,953 - $215,724	2,249 New	2,249 $211,000

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Wetherby Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Wetherby Asset Management Inc with notifications on news.